logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jin‐Yuan Shih

national taiwan university hospital

63H-index
479Paper Count
1.8WCitation Count
Published Papers 126
Publication Date
logo
Response to comments on “Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy”
errJournal of the Formosan Medical Association
IF2.5
err2026-06-26
err0
errOAAI
errJenn-Yu Wu; Jianmin Zhuo; Ji-Fan Hsieh; Jin-Yuan Shih
errShare
errSave
Few-Shot Lung Cancer Classification via Electronic Nose Using Large Language Models: A Multicentre Prospective Study
errRespirology
IF6.3
err2026-05-21
err0
PREAI
errMeng-Rui Lee; Chien-Chi Huang; Joyce Yue Sun; Chang-Ru Lin; Wen-Yuan Lin; Nai-Hui Chi; Kea-Tiong Tang; Jann-Yuan Wang; Chao-Chi Ho; Jin-Yuan Shih; Chong-Jen Yu
errShare
errSave
Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy
errJournal of the Formosan Medical Association
IF2.5
err2026-04-06
err0
errOAAI
errJenn-Yu Wu; Jianmin Zhuo; Yi-Chun Chen; Sheau-Pey Wang; Ji-Fan Hsieh; Jin-Yuan Shih
errShare
errSave
Response to comments on PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study
errJournal of the Formosan Medical Association
IF2.5
err2026-04-01
err0
errOAAI
errYang, Ching-Yao; Shih, Jin-Yuan
errShare
errSave
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study
errLung Cancer
IF4.4
err2026-02-28
err0
PREAI
errSteven H. Lin; Doreen A Kahangire; Saurabh P Nagar; Myung-Ju Ahn; Raafet Affi; Jason Agulnik; Jin–Yuan Shih; Maximilian J Hochmair; Amanda Tufman; Didier Debieuvre; Jason Chow; Maria Jimenez; Keith L. Davis; Martin Sandelin; Rajwanth R. Veluswamy
errShare
errSave
Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: a multicenter retrospective study
errESMO Open
IF8.3
err2025-12-29
err0
errOAAI
errS.-C. Chang; C.-Y. Huang; Y.-C. Lai; M.-S. Hsieh; C.-C. Ho; C.-Y. Yang; J.-Y. Shih; S.-G. Wu; P.-W. Hu; C.-L. Hsu; C.-Y. Chen; W.-Y. Liao
errShare
errSave
Real-world effectiveness of lorlatinib in previously treated ROS1 positive NSCLC patients in Taiwan
errJournal of the Formosan Medical Association
IF2.5
err2025-11-06
err0
errOAAI
errJin-Yuan Shih; Ching-Yao Yang; Yung-Hung Luo; Gee-Chen Chang; Xuet-Yit Chen; Wei-Tse Fang
errShare
errSave
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC
errJournal of Biomedical Science
IF12.1
err2025-10-11
err0
errOAAI
errChia-Chi Hsu; Derek De-Rui Huang; Wei-Hsun Hsu; Min-Shu Hsieh; Fang-Yu Lin; Pei-Chen Tai; Shih-Yun Chou; Hsin-Hui Tsai; Chen-Yuan Tseng; Bin-Chi Liao; Jin-Yuan Shih; James Chih-Hsin Yang
errShare
errSave
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study
errESMO Open
IF8.3
err2025-09-24
err0
PREAI
errP. Schöffski; A. Gazzah; J. Trigo; A. Italiano; P. Gougis; V. Subbiah; J.-Y. Shih; H.H. Loong; B. Doger; M. Keegan; B. Jeglinski; K. Andreas; B.C. Cho
errShare
errSave
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
errJournal of Thoracic Oncology
IF20.8
err2025-09-09
err0
errOAAI
errByoung Chul Cho; Weimin Li; Alexander I. Spira; Maxwell Sauder; Jill Feldman; Farastuk Bozorgmehr; Milena Mak; Janellen Smith; Pei Jye Voon; Baogang Liu; Panwen Tian; Jiunn-Liang Tan; Cheng-Ta Yang; Jin-Yuan Shih; Nuri Karadurmus; Juan Esteban Cundom; Glaucio Bertollo; Irfan Cicin; Jorge Nieva; Ana Laura Ortega-Granados; Pascale Tomasini; Danny Nguyen; Enriqueta Felip; Julia Schuchard; Sean P. Murphy; Bailey G. Anderson; Tonatiuh Romero; Yichuan Xia; Shubin Sheng; Joshua M. Bauml; Parthiv J. Mahadevia; Julian Kam; Mehregan Nematian-Samani; Jairo Simoes; Mark Wildgust; Nicolas Girard
errShare
errSave
Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants
errClinical Lung Cancer
IF3.3
err2025-03-21
err0
errOAAI
errLih-Chyun Chang; Hsiang-Wei Hu; Min-Shu Hsieh; Shang-Gin Wu; Jin-Yuan Shih
errShare
errSave
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis
errNEOPLASIA
IF7.7
err2025-02-01
err0
errOAAI
errLiang, Sheng-Kai; Liao, Wei-Yu; Shih, Jin-Yuan; Hsu, Chia-Lin; Yang, Ching-Yao; Wu, Shang-Gin; Lin, Yen-Ting; Wen, Yueh-Feng; Chen, Lun-Che; Chen, Yen-Fu; Chen, Ya-Fang; Lin, Yen-Heng; Yu, Chong-Jen
errShare
errSave
Lipid Levels and Lung Cancer Risk: Findings from the Taiwan National Data Systems from 2012 to 2018
errJOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH
IF3.1
err2025-01-30
err0
errOAAI
errChen, Jung-Yueh; Chi, Nai-Hui; Lee, Ho-Shen; Hsiung, Chia-Ni; Wu, Chang-Wei; Fan, Kang-Chi; Lee, Meng-Rui; Wang, Jann-Yuan; Ho, Chao-Chi; Shih, Jin-Yuan
errShare
errSave
Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report
errJournal of Thoracic Oncology
IF20.8
err2025-01-24
err0
errOAAI
errAlexander I. Spira; Luis Paz-Ares; Ji-Youn Han; Jin-Yuan Shih; Céline Mascaux; Upal Basu Roy; Jon Zugazagoitia; Yu Jung Kim; Chao-Hua Chiu; Sang-We Kim; Ernest Nadal; Ignacio Gil-Bazo; Sean P. Murphy; Bailey G. Anderson; Yichuan Xia; George Wang; Joshua M. Bauml; Marc Chioda; Jairo Simoes; Parthiv J. Mahadevia; Gilberto Lopes
errShare
errSave
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
errCLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
err2024-12-23
err0
errOAAI
errWu, Shang-Gin; Ho, Chao-Chi; Yang, James Chih-Hsin; Yu, Shu-Han; Lin, Yen-Feng; Lin, Shu-Chin; Liao, Bin-Chi; Yang, Ching-Yao; Lin, Yen-Ting; Yu, Chong-Jen; Chuang, Ya-Ting; Liao, Wei-Yu; Yap, Kah Yi; Kou, Weng Si; Shih, Jin-Yuan
errShare
errSave
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study
errJournal of the Formosan Medical Association
IF2.5
err2024-12-17
err0
errOAAI
errChing-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chia-Chi Hsu; Yi-Nan Liu; Guan-Ru Peng; Almanzo Aeterna Kangartaputra; Shu-Han Yu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James Chih-Hsin Yang
errShare
errSave
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2024-11-01
err5
PREAI
errNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin
errShare
errSave
Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failure
errJournal of the Formosan Medical Association
IF2.5
err2024-08-16
err0
errOAAI
errZong-Han Yao; Wei-Yu Liao; Chin-Yao Yang; Chao-Chi Ho; Jin-Yuan Shih; Kuan-Yu Chen; James Chih-Hsin Yang; Chong-Jen Yu
errShare
errSave
Hope and its relationship with treatment/ physical related factors in lung cancer patients receiving immunotherapy
errJournal of the Formosan Medical Association
IF2.5
err2024-07-06
err0
errOAAI
errChih-Chien Hsu; Yun-Hsiang Lee; Min-Ru Chen; Chih-Hsin Yang; Jin-Yuan Shih; Wei-Yu Liao; Meng-Ping Hsiao; Yeur-Hur Lai
errShare
errSave
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44
errMOLECULAR THERAPY NUCLEIC ACIDS
IF6.1
err2024-03-01
err5
errOAAI
errWu, Shang-Gin; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; Huang, Yen-Lin; Hsu, Chia-Lang; Jheng, Han-Nian; Shih, Jin-Yuan
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
M
Marc Ladanyi
H-index: 204 · Papers: 2.5K
G
Gabriel N. Hortobágyi
H-index: 187 · Papers: 1.9K
M
Mien‐Chie Hung
H-index: 163 · Papers: 1.5K
A
Adi F. Gazdar
H-index: 161 · Papers: 1.2K
V
Valerie W. Rusch
H-index: 161 · Papers: 1.1K
View more